Sugi Predict

Sugi Predict / Compounds / SCHEMBL7049647

SCHEMBL7049647

SCHEMBL7049647

CN(C)CC(=O)Nc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.60
▸ TAAR1 Q96RJ0 1/20 0.58
▸ ALDH1A1 P00352 3/20 0.55
▸ L3MBTL1 Q9Y468 2/20 0.55
▸ EPHX2 P34913 1/20 0.55
▸ GAA P10253 1/20 0.55
▸ SCN1A P35498 1/20 0.55
▸ SCN2A Q99250 1/20 0.55
▸ SCN3A Q9NY46 1/20 0.55
▸ HDAC3 O15379 2/20 0.53
▸ HDAC4 P56524 2/20 0.53
▸ HDAC1 Q13547 2/20 0.53
▸ HDAC7 Q8WUI4 2/20 0.53
▸ HDAC2 Q92769 2/20 0.53
▸ HDAC10 Q969S8 2/20 0.53
▸ HDAC11 Q96DB2 2/20 0.53
▸ HDAC8 Q9BY41 2/20 0.53
▸ HDAC6 Q9UBN7 2/20 0.53
▸ HDAC9 Q9UKV0 2/20 0.53
▸ HDAC5 Q9UQL6 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7053170 0.98 MAPT (0.58) MAPTTAAR1ALDH1A1L3MBTL1EPHX2
SCHEMBL15506017 0.88 ALDH1A1 (0.60) MAPTALDH1A1EPHX2GAASCN1A
SCHEMBL28939771 0.85 RAB9A (0.66) MAPTTAAR1ALDH1A1L3MBTL1LTA4H
SCHEMBL9639810 0.83 HDAC1 (0.59) MAPTALDH1A1L3MBTL1EPHX2GAA
SCHEMBL1066727 0.83 MAPT (0.59) MAPTTAAR1ALDH1A1L3MBTL1LTA4H
SCHEMBL764662 0.82 POLB (0.68) MAPTTAAR1ALDH1A1L3MBTL1GAA
SCHEMBL10916539 0.82 MAPT (0.63) MAPTTAAR1ALDH1A1L3MBTL1GAA
SCHEMBL404335 0.82 RAB9A (0.58) MAPTTAAR1ALDH1A1L3MBTL1LTA4H
SCHEMBL21966135 0.82 MAPT (0.53) MAPTALDH1A1L3MBTL1EPHX2GAA
SCHEMBL1409656 0.81 MAPT (0.66) MAPTTAAR1ALDH1A1L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114874366-A Multi-center loaded metalloporphyrin complex and preparation method thereof as well as preparation method of carbon dioxide-based polymer 中国科学院长春应用化学研究所 2022-08-09 — — CN disclosed
EP-2417140-B1 INHIBITORS OF HIV REPLICATION BOEHRINGER INGELHEIM INT (DE) 2014-11-26 — — EP disclosed
US-20140242174-A1 TREATING COUGH AND TUSSIVE ATTACKS VERONA PHARMA PLC (GB) 2014-08-28 — — US disclosed
CN-103974699-A Treating cough and tussive attacks VERONA PHARMA PLC 2014-08-06 — — CN disclosed
CN-103906742-A Selenophene-fused aromatic compound and manufacturing method thereof UNIV SEJONG IND ACAD COOP GR 2014-07-02 — — CN disclosed
WO-2014037727-A1 CARCAINIUM SALTS VERONA PHARMA PLC (GB) 2014-03-13 — — WO disclosed
WO-2014037726-A1 LIQUID PHARMACEUTICAL COMPOSITIONS VERONA PHARMA PLC (GB) 2014-03-13 — — WO disclosed
WO-2014037727-A1 CARCAINIUM SALTS VERONA PHARMA PLC (GB) 2014-03-13 — — WO disclosed
WO-2014037726-A1 LIQUID PHARMACEUTICAL COMPOSITIONS VERONA PHARMA PLC (GB) 2014-03-13 — — WO disclosed
WO-2013034909-A1 TREATING COUGH AND TUSSIVE ATTACKS VERONA PHARMA PLC (GB) 2013-03-14 — — WO disclosed
EP-1087760-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF COUGH Nortran Pharmaceuticals Inc. (CA) 2001-04-04 — — EP disclosed
CN-1276722-A N, N-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives thereof for the treatment of pain NORTRAN PHARMACEUTICALS INC (CA) 2000-12-13 — — CN disclosed
EP-1009397-A2 N,N-BIS (PHENYLCARBAMOYLMETHYL) DIMETHYLAMMONIUM CHLORIDE AND DERIVATIVES IN THE TREATMENT OF PAIN Nortran Pharmaceuticals Inc. (CA) 2000-06-21 — — EP disclosed
EP-1009397-A2 N,N-BIS (PHENYLCARBAMOYLMETHYL) DIMETHYLAMMONIUM CHLORIDE AND DERIVATIVES IN THE TREATMENT OF PAIN Nortran Pharmaceuticals Inc. (CA) 2000-06-21 — — EP disclosed
WO-1999063985-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF COUGH NORTRAN PHARMACEUTICALS, INC. (CA) 1999-12-16 — — WO disclosed
WO-1999011252-A3 N,N-BIS (PHENYLCARBAMOYLMETHYL) DIMETHYLAMMONIUM CHLORIDE AND DERIVATIVES IN THE TREATMENT OF PAIN NORTRAN PHARMACEUTICALS INC (CA) 1999-05-06 — — WO disclosed
WO-1999011252-A2 N,N-BIS (PHENYLCARBAMOYLMETHYL) DIMETHYLAMMONIUM CHLORIDE AND DERIVATIVES IN THE TREATMENT OF PAIN NORTRAN PHARMACEUTICALS, INC. (CA) 1999-03-11 — — WO disclosed
WO-1999011252-A2 N,N-BIS (PHENYLCARBAMOYLMETHYL) DIMETHYLAMMONIUM CHLORIDE AND DERIVATIVES IN THE TREATMENT OF PAIN NORTRAN PHARMACEUTICALS, INC. (CA) 1999-03-11 — — WO disclosed
US-4093640-A HAIR DYES L'OREAL (FR) 1978-06-06 — — US disclosed
US-3984443-A Indamines for dyeing keratinic fibers L'OREAL (FR) 1976-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140242174-A1 TREATING COUGH AND TUSSIVE ATTACKS SLC6A6, ASIC1, ASIC3 MAPT 1835/4885TAAR1 67/4885ALDH1A1 1645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.